The independent source for health policy research, polling, and news.
2,241-2,260 of 4,001 results
NYU’s promise to help keep medical students debt-free generates joy on campus. But critics question whether it is the best way to recruit a more diverse student pool or get young doctors to commit to primary care.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
Medicare limits payments for valve replacement via a catheter to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
Some hospitals have taken steps to be more energy-efficient. Though at times these changes barely represent rounding errors in their budgets, comprehensive efforts are beginning to make a difference.
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last month.
KHN's Shefali Luthra talks about how the American Medical Association's student caucus managed to push the overall organization to begin reviewing and possibly — eventually — reconsider its decades-long opposition to single-payer health care.
Unlike most other workers, private-ambulance employees are frequently called away from their meals and rest breaks to respond to emergency calls, but there’s no law explicitly allowing that practice. Proposition 11 would change that, but some say its real purpose is to get California's largest ambulance company out of costly litigation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
The moves could lead to a dramatic decrease in hospitals and doctors participating in the program, industry officials said.
A Kaiser Health News and USA Today Network investigation finds that a hodgepodge of state rules governing outpatient centers allow some deaths and serious injuries to go unexamined. And no rule stops a doctor exiled by a hospital for misconduct from opening a surgery center down the street.
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws.
The New York congressman was a major investor in an Australian biotechnology firm and prosecutors allege that he tipped off his son and others to sell stock shortly before the company reported poor results in its drug testing.
© 2026 KFF